| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |